Rifaximin is a semisynthetic, rifamycin-based non-systematic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is primarily used to treat diarrhea caused by E. coli, but recent studies published in the American Journal of Gastroenterology suggest its efficacy in relieving chronic functional symptoms of bloating and flatulence that are common in gastrointestinal disorders, such as Irritable Bowel Syndrome.

It is currently sold under the brand name Xifaxan® by Salix Pharmaceuticals.

References

---

• Sharara A, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, ElHajj I. A Randomized Double-Blind Placebo-Controlled Trial of Rifaximin in Patients with Abdominal Bloating and Flatulence. The American Journal of Gastroenterology, 101(2):326 — February 2006.
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Sixth Edition, Wayne PA. — January 2003
• Micromedex information on rifaximin
• FDA label approved for Xifaxan (PDF warning)

More on [ Rifaximin ]

Rifaximin - Twitter Search

Google- Salix Pharmaceuticals Gets Intellecutual Property Relating to Rifaximin - Trading Markets (press release) http://bit.ly/1eS9J
ibsgroup (ibsgroup) Sat, 07 Nov 2009 10:24:39 -0000
Google- Salix Pharmaceuticals Gets Intellecutual Property Relating to Rifaximin - Trading Markets (press release) http://bit.ly/1eS9J
Google- Salix Pharma gets US patent for Rifaximin - pharmabiz.com http://bit.ly/3xdXxb
ibsgroup (ibsgroup) Fri, 06 Nov 2009 13:25:21 -0000
Google- Salix Pharma gets US patent for Rifaximin - pharmabiz.com http://bit.ly/3xdXxb
Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin (Business Wire) (http://cli.gs/r0zEN)
BestDailyStocks (BestDailyStocks.Info) Wed, 04 Nov 2009 13:38:33 -0000
Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin (Business Wire) (http://cli.gs/r0zEN)
Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin (Business Wire): RALEIGH,.. http://bit.ly/4znV9b
Dr_Raj_Miniyar (Dr. Raj Miniyar) Tue, 03 Nov 2009 15:33:34 -0000
Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin (Business Wire): RALEIGH,.. http://bit.ly/4znV9b

Subscribe to Rifaximin RSS feed